Related references
Note: Only part of the references are listed.Potent transglutaminase inhibitors, dithio beta-aminoethyl ketones
Shoichiro Ozaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Acylideneoxoindoles: A new class of reversible inhibitors of human transglutaminase 2
Cornelius Kloeck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Dihydroisoxazole Analogs for Labeling and Visualization of Catalytically Active Transglutaminase 2
Laila Dafik et al.
CHEMISTRY & BIOLOGY (2011)
Screening of substrate peptide sequences for tissue-type transglutaminase (TGase 2) using T7 phage cDNA library
Yoshiaki Sugimura et al.
CYTOTECHNOLOGY (2011)
Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease
Robin Verhaar et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Cytosolic Guanine Nucledotide Binding Deficient Form of Transglutaminase 2 (R580a) Potentiates Cell Death in Oxygen Glucose Deprivation
Gozde Colak et al.
PLOS ONE (2011)
Potent transglutaminase inhibitors, aryl β-aminoethyl ketones
Shoichiro Ozaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
A Profiling Platform for the Characterization of Transglutaminase 2 (TG2) Inhibitors
Sabine Schaertl et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
Preferred substrate sequences for transglutaminase 2: screening using a phage-displayed peptide library
Kiyotaka Hitomi et al.
AMINO ACIDS (2009)
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
Ellen M. Sletten et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Photolabeling of Tissue Transglutaminase Reveals the Binding Mode of Potent Cinnamoyl Inhibitors
Christophe Pardin et al.
BIOCHEMISTRY (2009)
Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits
Masanobu Okauchi et al.
BRAIN RESEARCH (2009)
Increased TG2 Expression Can Result in Induction of Transforming Growth Factor β1, Causing Increased Synthesis and Deposition of Matrix Proteins, Which Can Be Regulated by Nitric Oxide
Dilek Telci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Transglutaminase inhibition ameliorates experimental diabetic nephropathy
Linghong Huang et al.
KIDNEY INTERNATIONAL (2009)
Synthesis of potent water-soluble tissue transglutaminase inhibitors
Martin Griffin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase
Christophe Pardin et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
Identification of Chemical Inhibitors to Human Tissue Transglutaminase by Screening Existing Drug Libraries
Thung-S. Lai et al.
CHEMISTRY & BIOLOGY (2008)
Cinnamoyl inhibitors of tissue transglutaminase
Christophe Pardin et al.
JOURNAL OF ORGANIC CHEMISTRY (2008)
Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue Injury
Matthew Siegel et al.
PLOS ONE (2008)
Transglutaminase 2 undergoes a large conformational change upon activation
Daniel M. Pinkas et al.
PLOS BIOLOGY (2007)
Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease
Tim S. Johnson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Transglutaminase 2 inhibitors and their therapeutic role in disease states
Matthew Siegel et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor
April Case et al.
BIOCHEMISTRY (2007)
Synthesis and evaluation of peptidic maleimides as transglutaminase inhibitors
Dany Halim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Synthesis and evaluation of peptidic irreversible inhibitors of tissue transglutaminase
Christophe Pardin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles
R. Edward Watts et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth
R. A. Jones et al.
CELL DEATH AND DIFFERENTIATION (2006)
Pharmacologic transglutaminase inhibition attenuates drug-primed liver hypertrophy but not Mallory body formation
P Strnad et al.
FEBS LETTERS (2006)
Structure-activity relationship study of novel tissue transglutaminase inhibitors
E Duval et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Chemistry and biology of dihydroisoxazole derivatives: Selective inhibitors of human transglutaminase 2
K Choi et al.
CHEMISTRY & BIOLOGY (2005)
Transglutaminases as targets for pharmacological inhibition
JM Wodzinska
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Identification of binding sites in the nicotinic acetylcholine receptor for [3H]azietomidate, a photoactivatable general anesthetic
MR Ziebell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tissue trans glutaminase acylation: Proposed role of conserved active site Tyr and Trp residues revealed by molecular modeling of peptide substrate binding
RA Chica et al.
PROTEIN SCIENCE (2004)
Structural basis for the coordinated regulation of transglutaminase 3 by guanine nucleotides and calcium/magnesium
B Ahvazi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium
W Baumgartner et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Transglutaminase 5 is regulated by guanine-adenine nucleotides
E Candi et al.
BIOCHEMICAL JOURNAL (2004)
A specific mechanism of nonspecific inhibition
SL McGovern et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Transglutaminases: Nature's biological glues
M Griffin et al.
BIOCHEMICAL JOURNAL (2002)
Synthesis of dipeptide-bound epoxides and α,β-unsaturated amides as potential irreversible transglutaminase inhibitors
P de Macédo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Synthesis and evaluation of novel dipeptide-bound 1,2,4-thiadiazoles as irreversible inhibitors of guinea pig liver transglutaminase
C Marrano et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Kinetic studies of guinea pig liver transglutaminase reveal a general-base-catalyzed deacylation mechanism
A Leblanc et al.
BIOCHEMISTRY (2001)
Evaluation of novel dipeptide-bound α,β-unsaturated amides and epoxides as irreversible inhibitors of guinea pig liver transglutaminase
C Marrano et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Share Paper
